AT-MSCs derived from T2D donors exhibited lower adipogenic differentiation capacity in vitro, as indicated by the lower expression of the adipogenesis-related gene – CEBPα and a decrease in the accumulation of lipid droplets characteristic of adipogenic differentiation when compared to AT-MSCs from healthy donors. This evidence concerns the gene CEBPA and type 2 diabetes mellitus.